Senior Technology Transfer Manager National Cancer Institute Technology Transfer Center Invention Development & Marketing Unit Dr. Joseph M. Conrad III is a Senior Technology Transfer Manager in the NCI Technology Transfer Center’s (TTC) Invention Development & Marketing Unit (IDMU).  He is responsible for increasing the visibility of technologies from the NCI and other NIH Institutes/Centers to increase in-licensing and collaborative opportunities with stakeholders who could potentially commercialize these technologies for patient populations needing new therapeutics and treatments. Relevant stakeholders include domestic and international bio, pharma and device industry companies; investors; state, local and international economic development officials; and non-government organizations.Prior to joining the IDMU, Dr. Conrad was a Technology Transfer Specialist in the NCI TTC, where prepared and negotiated agreements facilitating collaborations between several NIH Institutes and outside organizations to enable the transfer of NIH technology into the private sector.  Dr. Conrad is also responsible for educating NIH investigators on various aspects of patent law and technology marketing. Dr. Conrad has over 26 years of combined intellectual property law and technology transfer experience.  He’s a former USPTO Patent Examiner and has worked for two DC patent law firms, preparing and prosecuting pharmaceutical and biotechnology patent applications. He received his J.D. from the George Washington University Law School and received his Ph.D. in Biochemistry from the American University.